Error loading player: No playable sources found
AC24OD1
Cancer Risk Reduction Strategies for Transgender, Non-Binary, and Gender Diverse People with Hereditary Cancer Syndromes
Date
March 27, 2024
Explore related products in the following collection:
Use the 'Comments' tab to post questions for the speakers.
Learning Objectives
- Review the challenges faced by the transgender, non-binary, and gender diverse population during cancer diagnosis, surveillance, and treatment.
- Discuss gender affirming hormone therapies and their potential effect on cancer risks in transgender, non-binary, and gender diverse individuals with hereditary cancer syndromes.
- Identify possible cancer screening and risk-reducing strategies for patients in this population who have hereditary cancer syndromes.
Speakers
Julie S. Mak, MS, MSc, CGC
UCSF Helen Diller Family Comprehensive Cancer Center
Diego Rodriguez, MSN, RN, OCN
City of Hope National Medical Center
Related Products
Capturing Structured Data in the Electronic Health Record
Use the 'Comments' tab to post questions for the speakers…
Updates to Treatment of Recurrent/Metastatic Head and Neck Cancers
Use the 'Comments' tab to post questions for the speakers…
Management of Cancer-Related Fatigue
Use the 'Comments' tab to post questions for the speakers…
